Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/03/85/bf/0385bf00-4f5f-1d37-7e70-cdfd5676802b/mza_1155440752639581066.jpeg/600x600bb.jpg
"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
Christina Farr, Luba Greenwood, Ash Zenooz
39 episodes
4 months ago
If you’re obsessed with health-tech and life sciences, this is the podcast for you. Second Opinion doesn't hold back. Join Luba Greenwood, Christina Farr, and Ash Zenooz as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Healthcare, health-tech and life sciences in particular, is hard to navigate even for the most seasoned professionals. Unpacking the latest technological, medical, and scientific advances, regulatory hurdles, global economic shifts, and industry and investment trends, requires a powerful combination of hosts like us. We aim to sift through the noise and help you navigate what’s really going on in healthcare and how to spot the next win. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space. Christina Farr is a former investigative journalist for CNBC — during her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. Now Christina is the author at Second Opinion, a newsletter with +20K subscribers. Joining Christina are co-hosts Luba Greenwood, JD — former CEO of Kojin Therapeutics and managing partner at Dana-Farber Cancer Institute — and Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings.  Second Opinion is is a part of the Turpentine podcast network. Learn more: turpentine.co
Show more...
Technology
Business,
Investing,
Health & Fitness
RSS
All content for "Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD is the property of Christina Farr, Luba Greenwood, Ash Zenooz and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
If you’re obsessed with health-tech and life sciences, this is the podcast for you. Second Opinion doesn't hold back. Join Luba Greenwood, Christina Farr, and Ash Zenooz as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Healthcare, health-tech and life sciences in particular, is hard to navigate even for the most seasoned professionals. Unpacking the latest technological, medical, and scientific advances, regulatory hurdles, global economic shifts, and industry and investment trends, requires a powerful combination of hosts like us. We aim to sift through the noise and help you navigate what’s really going on in healthcare and how to spot the next win. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space. Christina Farr is a former investigative journalist for CNBC — during her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. Now Christina is the author at Second Opinion, a newsletter with +20K subscribers. Joining Christina are co-hosts Luba Greenwood, JD — former CEO of Kojin Therapeutics and managing partner at Dana-Farber Cancer Institute — and Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings.  Second Opinion is is a part of the Turpentine podcast network. Learn more: turpentine.co
Show more...
Technology
Business,
Investing,
Health & Fitness
https://megaphone.imgix.net/podcasts/3d20d36c-3608-11f0-aa17-0779d8678ef2/image/5785b7c26c952e12c58d2babe341c756.png?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress
Healthcare’s “original sin” with Stephen Buck, CEO of Courage Health
"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
31 minutes
6 months ago
Healthcare’s “original sin” with Stephen Buck, CEO of Courage Health
This week on Second Opinion, Christina Farr and Ash Zenooz interview Stephen Buck, CEO/Co-Founder of Courage Health, a public benefit company providing cancer survival rates to patients and physicians, helping facilitate conversations about living life to the fullest. They talk about the inefficacy of employer-based healthcare, the lack of political bipartisan collaboration, and the rising trend of direct-to-consumer healthcare models. —📰 Be notified early when Turpentine drops new publication: https://www.turpentine.co/exclusiveaccess —SPONSOR:🏋🏻‍♀️Strengthen your cells from the inside-out with Fatty15, a pure C15 supplement proven to boost energy, improve sleep, and support metabolic, heart, and liver health – without the downsides of fish oil. Ready to restore your long-term health? Get 15% off your 90-day subscription Starter Kit at https://fatty15.com/secondopinion using code SECONDOPINION at checkout. —LINKS: Courage Health: https://courage.health/ Stephen Buck (CNBC Healthy Returns): https://www.cnbc.com/2018/03/20/stephen-buck.html  Christina Farr's Second Opinion Newsletter: https://secondopinion.media/—FOLLOW:https://www.linkedin.com/in/christinafarr/ https://www.linkedin.com/in/ashzenooz/ —HIGHLIGHTS FROM THE EPISODE:• Bipartisan collaboration is necessary for meaningful healthcare reform.• Employer-based healthcare creates fundamental misalignments in the American system.• Short employee tenure (2-3 years) eliminates incentives for long-term health investment.• Consumers willingly pay premium prices for convenient, private healthcare services.• Preventive services offered by employers remain largely underutilized.• "Longevity" branding resonates more effectively than traditional "prevention" messaging.• Cultural attitudes vary widely regarding health optimization versus quality of life.• Knowledge gaps exist between specialized medicine and primary care.• AI tools could potentially serve as co-pilots for patients and clinicians.• Consumer education about healthcare system misalignments is essential for self-advocacy.
"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
If you’re obsessed with health-tech and life sciences, this is the podcast for you. Second Opinion doesn't hold back. Join Luba Greenwood, Christina Farr, and Ash Zenooz as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Healthcare, health-tech and life sciences in particular, is hard to navigate even for the most seasoned professionals. Unpacking the latest technological, medical, and scientific advances, regulatory hurdles, global economic shifts, and industry and investment trends, requires a powerful combination of hosts like us. We aim to sift through the noise and help you navigate what’s really going on in healthcare and how to spot the next win. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space. Christina Farr is a former investigative journalist for CNBC — during her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. Now Christina is the author at Second Opinion, a newsletter with +20K subscribers. Joining Christina are co-hosts Luba Greenwood, JD — former CEO of Kojin Therapeutics and managing partner at Dana-Farber Cancer Institute — and Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings.  Second Opinion is is a part of the Turpentine podcast network. Learn more: turpentine.co